Phase 2 Stomach Cancer Trial, Recruiting NCT07212933 Sponsor: Chinese PLA General Hospital Condition: Stomach Cancer
Back to Stomach Cancer

Phase 2 Stomach Cancer Trial, Recruiting

NCT07212933
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing to take part and are happy to sign a consent form agreeing to join the study
  • You are aged 18 to 70 years old
  • You have been diagnosed with Stage IV (advanced/spread) stomach cancer or cancer at the junction of the stomach and food pipe, confirmed by a camera test of the stomach or a scan (CT or PET-CT), with cancer that has spread to other parts of the body such as the liver, lungs, or lymph nodes
  • Your cancer has stopped responding to, or got worse during, previous treatments such as chemotherapy, targeted therapy, or immunotherapy
  • You have at least one measurable tumour that can be tracked on a CT or MRI scan, and this scan was done within 28 days before starting treatment
  • Your general health and ability to carry out daily activities falls within an acceptable range (a score of 0–3 on a standard medical scale used by doctors)
  • Your doctors expect you to live for at least 1 month
  • You are able to understand what the study involves and agree to take part in writing

Who may not be able to join:

  • You currently have another type of cancer at the same time
  • You have serious heart, lung, or brain conditions
  • Your doctors expect you to live for less than 1 month
  • Your blood test results show your bone marrow is not working well enough — for example, low red blood cells, white blood cells, or platelets (confirm with trial site for exact values)
  • Your liver is functioning very poorly (confirm with trial site)
  • You have serious kidney disease (confirm with trial site)
  • You have a significant problem with blood clotting, shown by abnormal blood test results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 86-010-66937523

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Chinese PLA General Hospital
Registry
ClinicalTrials.gov
Start date
1 July 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Progression-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov